Approval for the Impella RP System. This device is indicated for providing temporary right ventricular support for up to 14 days in patients with a body surface area greater than or equal to 1.5 m2, who develop acute right heart failure or decompensation following left ventricular assist device  implantation, myocardial infarction, heart transplant, or open-heart surgery.